Greg Rossi discusses the imperative to address cancer in Europe with early detection, precision medicine and equitable access. Stressing the need for urgent action to make cancer a manageable condition, highlighting disparities and the importance of innovation.
As Europe enters a new legislative cycle, it charts a decisive course for the future of its life sciences sector, and the wellbeing of its citizens - navigating rapid advances in medical technology, while grappling with systemic healthcare challenges.
Innovation in science is advancing cancer care through early detection and treatment, bringing significant economic benefits to healthcare systems. Future incentives for innovation, particularly early detection and treatment approaches, must be recognised so that patients can benefit from this progress.
Over two years after the start of the COVID-19 pandemic, countries across Europe have been lifting restrictions and societies have gradually begun returning to ‘normal’ life. With over 75% of the European population having been vaccinated with at least one …
The need to stop the spread of COVID-19, to save lives and to reduce hospitalisations, remains as vital and urgent as ever. To vaccinate the entire world as quickly as possible, international organisations, governments, health leaders, industry, and civil society must do more, writes Iskra Reić.
Heart failure poses a significant challenge in Europe, affecting nearly 15 million people in the region. As we move into 2021, it’s important that we take learnings from the COVID-19 crisis on board, including the relatively simple measures we can take to avoid hospitalisations and death.
We’re all in the race of our lives to beat COVID-19. Scientists are setting an astonishing pace in a team effort with healthcare professionals, policymakers and entire populations. But at the same time it’s imperative we maintain the momentum we’ve …
